RNA splicing dysregulation is a hallmark of cancer but remains poorly understood in solid tumors. Here, the authors map splicing patterns in lung adenocarcinoma, uncover a CMTR2-mutant subtype, and show its vulnerability to splicing modulators and immunotherapy.
- Shigenari Nukaga
- Kouya Shiraishi
- Takashi Nakaoku
